BiotechTube
Home/Chemestmed/Sigrid Selberg, Ph.D.
SS

Sigrid Selberg, Ph.D.

Chief Scientific Officer

Chemestmed

Therapeutic Areas

CNS DisordersMetabolic DiseasesOncology

Chemestmed Pipeline

DrugIndicationPhase
METTL3/METTL14 ActivatorsAnxiety, Parkinson's Disease, Type 2 Diabetes, ObesityPreclinical
METTL16/ALKBH5/FTO/Reader InhibitorsOncology, Neurodegenerative DiseasesPreclinical

Leadership Team at Chemestmed

NS
Neinar Seli, Ph.D.
Founder and CEO
EA
Erik Allikmets, M.D.
Chief Medical Officer
SS
Simona Selberg, Ph.D.
Head of Research and Development
View full Chemestmed profile